Hospitalized Acute Exacerbation of COPD Impairs Flow and Nitroglycerin-Mediated Peripheral Vascular Dilation

REFERENCES

• Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2(1):8–11.
   PubMedGoogle Scholar
• Marcus EB, Curb JD, MacLean CJ, Reed DM, Yano K. Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol 1989; 129(1):97–104.
   PubMed Web of Science ®Google Scholar
• Persson C, Bengtsson C, Lapidus L, Rybo E, Thiringer G, Wedel H. Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol 1986; 124(6):942–948.
   PubMed Web of Science ®Google Scholar
• Zvezdin B, Milutinov S, Kojicic M, Hadnadjev M, Hromis S, Markovic M, A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest 2009;136(2):376–380.
   PubMed Web of Science ®Google Scholar
• Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E Jr, Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16(1):63–70.
   PubMed Web of Science ®Google Scholar
• Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22(5):809–814.
   PubMed Web of Science ®Google Scholar
• Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106(20):2555–2560.
   PubMed Web of Science ®Google Scholar
• Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154(4 Pt 1):1055–1060.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 2000; 84(2):210–215.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174(8):867–874.
   PubMed Web of Science ®Google Scholar
• Malo O, Sauleda J, Busquets X, Miralles C, Agusti AG, Noguera A. Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2002; 38(4):172–176.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Livnat G, Girish M, Cabral H, Masdin P, Linacre P, Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD. Chest 2007; 131(1):37–43.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis—An inflammatory disease. N Engl J Med 1999; 340(2):115–126.
   PubMed Web of Science ®Google Scholar
• Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003;107(13):1783–1790.
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: A marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23(2):168–175.
   PubMed Web of Science ®Google Scholar
• Gokce N, Keaney JF, Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41(10):1769–1775.
   PubMed Web of Science ®Google Scholar
• Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101(16):1899–1906.
   PubMed Web of Science ®Google Scholar
• Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129(1):111–118.
   PubMed Web of Science ®Google Scholar
• Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32(1):123– 127.
   PubMed Web of Science ®Google Scholar
• Meyer B, Mortl D, Strecker K, Hulsmann M, Kulemann V, Neunteufl T, Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: Comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005; 46(6):1011–1018.
   PubMed Web of Science ®Google Scholar
• Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34(1):146–154.
   PubMed Web of Science ®Google Scholar
• Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102(9):994–999.
   PubMed Web of Science ®Google Scholar
• Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178(12):1211–1218.
   PubMed Web of Science ®Google Scholar
• Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves AP, Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 2007; 176(12):1200–1207.
   PubMed Web of Science ®Google Scholar
• Tillie-Leblond I, Marquette CH, Perez T, Scherpereel A, Zanetti C, Tonnel AB, Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006; 144(6):390–396.
   PubMed Web of Science ®Google Scholar
• Crookshank AD, Travaline JM, Ciccolella DE, Rogers T, Kashem A, Santamore WP, Endothelial dysfunction in acute exacerbation of COPD and at Baseline. AJ Resp CCM 2007; 175:A514.
   Google Scholar
• Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117(5 Suppl 2):398S–401S.
   PubMed Web of Science ®Google Scholar
• Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39(2):257–265.
   PubMed Web of Science ®Google Scholar
• Gokce N, Holbrook M, Duffy SJ, Demissie S, Cupples LA, Biegelsen E, Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension 2001; 38(6):1349–1354.
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 2005;127(6):2254–2263.
   PubMed Web of Science ®Google Scholar
• Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology 2008;59(3):357–364.
   PubMed Web of Science ®Google Scholar
• Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175(12):1259–1265.
   PubMed Web of Science ®Google Scholar
• Tockman MS, Pearson JD, Fleg JL, Metter EJ, Kao SY, Rampal KG, Rapid decline in FEV1. A new risk factor for coronary heart disease mortality. Am J Respir Crit Care Med 1995; 151(2 Pt 1):390–398.
   PubMed Web of Science ®Google Scholar
• Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124(2):459–467.
   PubMed Web of Science ®Google Scholar
• Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002; 57(2):137– 141.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003; 92(1):81–87.
   PubMed Web of Science ®Google Scholar
• Dover AR, Hadoke PW, Walker BR, Newby DE. Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans. J Cardiovasc Pharmacol 2007; 50(3):321– 326.
   PubMed Web of Science ®Google Scholar